1. Introduction {#sec1-molecules-25-00804}
===============

The Kurdistan region of Iraq has a rich biodiversity and many medicinal herbs, including *Eucalyptus* species, are used by local people in traditional medicine since time immemorial \[[@B1-molecules-25-00804]\]. A common antispasmodic and antipyretic remedy for treating respiratory tract diseases is prepared with the leaves of *Eucalyptus camaldulensis* Dehnh. (family Myrtaceae), also known as river red gum or Murrey red gum tree \[[@B2-molecules-25-00804]\]. A hot tea is made and then the vapors from the aromatic infusion are inhaled by sick people. The empirical knowledge of this traditional medicine is passed on by oral tradition. No scientific rationale has been reported so far and the mechanism of action remains largely uninvestigated.

The leaf essential oils isolated from *E. camaldulensis* collected in such different countries as Egypt \[[@B3-molecules-25-00804]\], Iran \[[@B4-molecules-25-00804],[@B5-molecules-25-00804],[@B6-molecules-25-00804]\], Kenya \[[@B7-molecules-25-00804]\], Montenegro \[[@B8-molecules-25-00804],[@B9-molecules-25-00804]\], Pakistan \[[@B10-molecules-25-00804],[@B11-molecules-25-00804]\], and Senegal \[[@B12-molecules-25-00804]\], to cite only some of the most recent studies, have been investigated. Moreover, the leaf oil of *E. camaldulensis* has been reported to have potent antiseptic, antimicrobial properties \[[@B9-molecules-25-00804],[@B13-molecules-25-00804],[@B14-molecules-25-00804]\], and it is commonly used in several countries for treating cough and cold, sore throat and other respiratory diseases \[[@B15-molecules-25-00804]\]. Indeed, compounds with spasmolytic activity have been isolated from an EtOH extract of *E. camaldulensis* var. *obtusa* leaves \[[@B16-molecules-25-00804]\]; however, the vasorelaxant effects of volatile fractions has been confirmed so far only by sporadic tests in vitro \[[@B17-molecules-25-00804]\].

Moreover, previous studies point out that there is a considerable variation in the yields and chemical compositions of the volatile fractions isolated from different samples of *E. camaldulensis*.

For these reasons, it was worthy to study the components of volatile fractions isolated from *E. camaldulensis* leaves collected in Iraqi--Kurdistan using various isolation techniques. Furthermore, the physiological effects of volatile fractions on respiratory physiology were investigated in detail with the aim of sustaining the traditional use of this antispasmodic remedy with scientific evidence. To this purpose, the relaxant effects of different volatile fractions on the contractility of isolated rat aortic and tracheal rings have been determined. Moreover, in order to shed light on the mechanism of action, the involvement of the Ca^2+^ and K^+^ channels, and the nitric oxide (NO) pathway in the biochemical processes underpinning the spasmolytic activity of the plant, was tested in vitro.

2. Results and Discussion {#sec2-molecules-25-00804}
=========================

Powdered air-dried leaves of *E. camaldulensis* were hydrodistilled in a standard Clevenger-type apparatus, by two different procedures, A and B, which are described in detail in [Section 3.4](#sec3dot4-molecules-25-00804){ref-type="sec"}. An oily volatile fraction, named EO~S~ was obtained by procedure A, named hydrodistillation with circulating-water. Three oils, named EO~W~, EO~A~, and EO~Ar~ were obtained by procedure B, named hydrodistillation with non-circulating water. Another crop of dried leaves was submitted to CO~2~ extraction at atmospheric pressure (see [Section 3.5](#sec3dot5-molecules-25-00804){ref-type="sec"}), which afforded an oily residue, named EO~D~. All the five oils had a pale yellowish color. They remained liquid even on storage at −20 °C in sealed vials and emanated a sharp and very distinct minty/pine smell. Each sample was dissolved in dichloromethane and analyzed by GC-FID and GC-MS.

2.1. Characteristics of the Volatile Fractions EO~S~ and EO~W~ {#sec2dot1-molecules-25-00804}
--------------------------------------------------------------

The densities of EOs and EO~W~ at 22 °C were 0.95 and 0.93 g/mL, respectively. They were practically insoluble at 22 °C in H~2~O and highly soluble in EtOH, dichloromethane and dimethyl sulfoxide (DMSO). Therefore, oil stock solutions for biological tests were prepared in DMSO.

2.2. Chemical Analysis of Volatile Fractions (EO) {#sec2dot2-molecules-25-00804}
-------------------------------------------------

The chemical compositions of the five different oily volatile fractions (EO) obtained by hydrodistillation (procedures A and B) and by CO~2~ extraction, are reported in [Table 1](#molecules-25-00804-t001){ref-type="table"}, together with the corresponding component percentages from GC-FID chromatograms and calculated linear retention indices (LRI). 31 components were identified in the volatile mixture EO~S~. Major components (see [Figure 1](#molecules-25-00804-f001){ref-type="fig"}) were 1,8-cineole (**1**, 62.70%), *p*-cymene (**2**, 6.70%), α-pinene (**3**, 4.71%), terpinen-4-ol (**4**, 3.86%), aromadendrene (**5**, 3.08%), and α-terpineol (**6**, 2.85%) which together accounted for the 83.9% EO~S~ ([Table 1](#molecules-25-00804-t001){ref-type="table"}). Forty-two compounds were identified in EO~W~, among which 1,8-cineole (59.09%), *p*-cymene (6.55%), aromadendrene (3.97%), terpinen-4-ol (3.9%), α-pinene (3.75), and α-terpineol (2.94%) were the most abundant ones, accounting for the 80.2 % EO~W~. 35 compounds were identified in EO~A~ and the most abundant ones were 1,8-cineole (53.41%), terpinen-4-ol (6.96%), α-terpineol (6.70%), cryptone (6.69%), and spathulenol (2.57%). EO~Ar~, contained 40 identified components and it was enriched in α-terpineol (17.26%), cryptone (13.92%), *p*-cymen-8-ol (13.48%), 1,8-cineole (10.14%), and spathulenol (5.74%). EO~D~ contained only ten identified components, among which 1,8-cineole (89.25%), *p*-cymene (3.44%), and spathulenol (2.58%) were the most abundant ones.

Considering all the volatile fractions ([Table 1](#molecules-25-00804-t001){ref-type="table"}), a total of sixty compounds were identified. They comprise 53 terpenoids, among which monoterpenoids (32) exceeded sesquiterpenoids (21) in number and total percentage. Oxygenated monoterpenoids (28) represented by far the most abundant family, followed by monoterpene hydrocarbons, whose number (4) was less than sesquiterpene hydrocarbons (12). 1,8-Cineole (eucalyptol) (**1**) was the most abundant oil component, followed by *p*-cymene (**2**), α-pinene (**3**), terpinen-4-ol (**4**), aromadendrene (**5**), and α-terpineol (**6**). Comparing the three different distillation procedures, hydrodistillation, either in mode A or B, afforded two oils, EO~S~ and EO~W~, in comparable yields, and having similar composition, and percentages of most components. In contrast, CO~2~ extraction was rather inefficient both in terms of oil (EO~D~) yield and chemical composition. In fact, only the rather non-polar compound 1,8-cineole (**1**) appeared to be removed from air-dried leaves in an efficient manner. The comparison of EO~A~ and EO~Ar~ with EO~W~ clearly showed that, as expected, the aqueous phase collected in the condenser was enriched in polar oxygenated monoterpenoids and sesquiterpenoids compared to non-polar terpenoid hydrocarbons. Specifically, borneol, terpinen-4-ol (**4**), cryptone, α-terpineol (**6**), and spathulenol exhibited a significant water solubility. Noticeable amounts of 1,8-cineole (**1**) were also dispersed in the aqueous phase. Moreover, comparison of EO~Ar~ with EO~A~ indicated that minor amounts of the most polar terpenoids were not completely removed from the aqueous phase by solid phase extraction (SPE, see [Section 3.3](#sec3dot3-molecules-25-00804){ref-type="sec"}).

Our data clearly showed that a significant quantity of oxygenated components remained dispersed in the aqueous phase collected in the condenser during leaf hydrodistillation. Therefore, we considered that a more accurate analysis of *E. camaldulensis* volatiles should include not only the components of the oil separated from the hydrosol, i.e., EO~W~, but also the mixture of polar compounds dispersed in the water condensed during the distillation process, i.e., EO~A~ and EO~Ar~. To this purpose, the column EO~Tot~ in [Table 1](#molecules-25-00804-t001){ref-type="table"} shows the sum of the percentages of each compound occurring in EO~W~, EO~A~, and EO~Ar~, averaged by the weight of each fraction. It thus resulted that the percentage of oxygenated monoterpenoids in the total volatile fraction EO~Tot~ was significantly higher than in the fraction EO~W~ alone, while that of hydrocarbons was lower. Only twelve components of EO~Tot~ had an abundance \> 1%, namely, 1,8-cineole (**1**, 55.83%), *p*-cymene (**2**, 4.80%), terpinen-4-ol (**4**, 4.56%), α-terpineol (**6**, 4.38%), aromadendrene (**5**, 2.97%), cryptone (2.90%), α-pinene (**3**, 2.73%), spathulenol (2.08%), 9-*epi*-(*E*)-caryophyllene (1.91%), *p*-mentha-3,8-diene (1.66%), globulol (1.48%), and *p*-menth-1-en-7-al (1.02%), which together accounted for 86.32% EO~Tot~.

Phytochemical results indicate that three chemotypes of *E. camaldulensis* can be distinguished on the basis of the main components of the oil obtained by hydrodistillation under analogous conditions: one rich in 1,8-cineole (28--84%), one rich in *p*-cymene (20--30%) and one rich in spathulenol (18%) \[[@B8-molecules-25-00804],[@B22-molecules-25-00804]\]. For example, the essential oil from *E. camaldulensis* leaves collected in Pakistan contained high concentration of oxygenated sesquiterpenes \[[@B11-molecules-25-00804]\], while the main components of the leaf oil hydrodistilled from *E. camaldulensis* collected in Iran were *p*-cymene (68.43%), 1,8-cineole (13.92%), α-pinene (3.45%), and limonene (2.84%) \[[@B4-molecules-25-00804]\]. Therefore, the compositions of EOs and EO~W~ clearly indicate that the variety of *E. camaldulensis* growing in Kurdistan can be classified as a chemotype with high 1,8-cineole and low *p*-cymene contents.

2.3. Relaxant Effects of E. camaldulensis Volatile Fractions on Aortic Rings {#sec2dot3-molecules-25-00804}
----------------------------------------------------------------------------

In a preliminary study we showed that the essential oil of *E. camaldulensis* produced a potent dilation in aortic force development probably acting as a Ca^2+^ channel antagonism and partially via NO and cyclooxygenase pathways \[[@B17-molecules-25-00804]\]. To investigate the relationship between oil composition and in vivo spasmolytic effects, the vasorelaxant effects of volatile fractions EO~S~, EO~W~, and EO~Ar~ on isolated rat aortic rings were determined separately, following the same procedure described previously \[[@B17-molecules-25-00804]\]. The concentration--response curves for the oil-induced relaxation against phenylephrine (PE)-induced contractions are shown in [Figure 2](#molecules-25-00804-f002){ref-type="fig"}, while the percentages of relaxation, the values of Log EC~50~, and 95% CI (Confidence Interval) for Log EC~50~ are shown in [Table 2](#molecules-25-00804-t002){ref-type="table"}. The curves show that the cumulative addition of the three samples at the plateau of contraction caused a relaxant effect in a concentration-dependent manner, with a strong potent dilation. Relaxation caused by EO~W~ did not differ significantly from EO~S~, as it could be anticipated by the comparable chemical compositions of the two oils; instead, significantly minor relaxation effects were observed for EO~Ar~. This finding seems to indicate that the reduced relaxant properties of EO~Ar~, compared to EO~S~ and EO~W~, is caused by the minor amount of 1,8-cineole (**1**) in EO~Ar~ (10.14%) than in EO~S~ (62.70%) and EO~W~ (59.09%). However, the physiological effects of EO~Ar~ were not totally suppressed, due to the significant presence of other active terpenoids ([Table 1](#molecules-25-00804-t001){ref-type="table"}), such as α-terpineol (**6**, 17.26%) \[[@B23-molecules-25-00804]\], spathulenol (5.74%) \[[@B24-molecules-25-00804]\], carvacrol (2.73%), and thymol (2.52%) \[[@B25-molecules-25-00804]\].

2.4. Relaxant Effects of EO~S~ and 1,8-Cineole (***1***) on Rat Tracheal Rings {#sec2dot4-molecules-25-00804}
------------------------------------------------------------------------------

Since the oil EO~S~ showed the highest activity on rat aortic rings, compared to EO~W~ and EOAr, we deemed it to be interesting to measure the relaxant effect of this volatile fraction also in rat tracheal rings. Moreover, the major component of EO~S~, namely the monoterpenoid 1,8-cineole (**1**), was also tested in parallel experiments. In fact, it is well-known that 1,8-cineole (**1**) displays a wide range of biological effects, including muscle relaxant, bronchodilatatory \[[@B26-molecules-25-00804],[@B27-molecules-25-00804],[@B28-molecules-25-00804],[@B29-molecules-25-00804]\], and anti-inflammatory \[[@B30-molecules-25-00804],[@B31-molecules-25-00804]\] properties. Therefore 1,8-cineole (1) was used as the reference compound and its contribution to the biological activity of the volatile fraction EO~S~ was roughly estimated. The concentration--response curves for 1,8-cineole (**1**) and EO~S~ relaxant effects against acetyl choline (ACh)-induced contractions are shown in [Figure 3](#molecules-25-00804-f003){ref-type="fig"}. The percentages of relaxation were 33.01% and 79.44% for 1,8-cineole (**1**) and EO~S~, respectively. On the other hand, the Log EC~50~ were 1.030 and 0.508 (mg/mL), respectively. These results clearly indicated that both 1,8-cineole (**1**) and EO~S~ produced potent concentration-dependent relaxation in rat tracheal rings precontracted with ACh (10 μM), although the activity of EO~S~ was much higher than that of 1,8-cineole (**1**) alone. These findings nicely agree with the results of other authors who suggested that the relaxant \[[@B26-molecules-25-00804],[@B32-molecules-25-00804]\] and cardiovascular \[[@B33-molecules-25-00804]\] effects induced by *Eucalyptus* essential oils appeared to derive from a complex interaction between various terpenoid components rather than being due to a single compound.

2.5. Relaxation Mechanism {#sec2dot5-molecules-25-00804}
-------------------------

Aimed at clarifying possible molecular mechanisms involved in the relaxation induced by EO~S~ in tracheal rings, we explored the effects of EO~S~ on the roles of the K~Ca~ and Ca^2+^ channels, and on NO release. Actually, the crucial roles of K~Ca~ and [l]{.smallcaps}-type Ca^2+^ channels, as well as NO release in airway smooth muscle contraction are well known \[[@B17-molecules-25-00804],[@B23-molecules-25-00804],[@B25-molecules-25-00804],[@B26-molecules-25-00804],[@B27-molecules-25-00804],[@B28-molecules-25-00804],[@B29-molecules-25-00804],[@B33-molecules-25-00804],[@B34-molecules-25-00804],[@B35-molecules-25-00804]\], and they are important therapeutic targets.

The concentration--response curve for the effect exerted by EO~S~ against tracheal rings precontracted with ACh (10 μM) and preincubated with the calcium-activated K^+^ (K~Ca~) channel blocker tetraethyl ammonium chloride (TEA), is shown in [Figure 4](#molecules-25-00804-f004){ref-type="fig"}, in comparison with the curve of the control. The two curves were almost superimposed, indicating that the inhibition of the K~Ca~ channel was not a significant signaling pathway.

In another experiment, we measured the relaxation induced by EO~S~ in tracheal rings precontracted with ACh (10 μM) and preincubated with the L-type Ca^2+^ channel blocker nifedipine (30 μM). The corresponding concentration--response curve with respect to the control is shown in [Figure 5](#molecules-25-00804-f005){ref-type="fig"}. In tracheal smooth muscle, blockade of voltage dependent Ca^2+^ channels (VDCs) by nifedipine at the extracellular surface of the membrane may attenuate bronchoconstriction \[[@B34-molecules-25-00804]\]. Spasm evoked by ACh and the maintenance of spontaneous tone largely depend on mechanisms for increasing the cytoplasmic concentration of free Ca^2+^ which are resistant to nifedipine \[[@B35-molecules-25-00804]\]. In the event, the relaxation effect induced by EO~S~ was significantly reduced, suggesting that the presence of active constituents in the EO~S~ can cause tracheal relaxation via the inhibition of Ca^2+^ influx through the plasma membrane in tracheal smooth muscle.

In the last experiment, the relaxant effect of EO~S~ in tracheal rings precontracted with ACh and preincubated with NG-nitro-L-arginine methyl ester (L-NAME) was measured. L-NAME is a very well-known endothelial NO synthase inhibitor. The concentration--response curve of EO~S~, compared to the control, is shown in [Figure 6](#molecules-25-00804-f006){ref-type="fig"}. The graphic shows that the relaxation was attenuated to some extent; however, EO~S~ was still quite effective (45.41% relaxation).

[Table 3](#molecules-25-00804-t003){ref-type="table"} shows the log EC~50~, the 95% CI values, and the percentages of tracheal ring relaxation calculated from the concentration--response curves ([Figure 4](#molecules-25-00804-f004){ref-type="fig"}, [Figure 5](#molecules-25-00804-f005){ref-type="fig"} and [Figure 6](#molecules-25-00804-f006){ref-type="fig"}) determined for EO~S~ in the three tests, compared to the control. In conclusion, these experiments clearly indicated that the pretreatment of tracheal rings with TEA or with L-NAME was unable to alter significantly the dose-dependent relaxant effects exerted by EO~S~. Therefore, the K~Ca~ channel and NO release and activation of the NO-cGMP pathway were not significantly involved in the relaxation mechanism. Instead, the inhibitory effect of EO~S~ in tracheal rings preincubated with nifedipine blocked the concentration--response relaxation, indicating that L-type Ca^2+^ channels were significantly (P \< 0.001) involved in the relaxation mechanism.

3. Materials and Methods {#sec3-molecules-25-00804}
========================

3.1. Plant Material {#sec3dot1-molecules-25-00804}
-------------------

Fresh leaves of *E. camaldulensis* Dehnh. were collected in January 2010 near the Duhok Damp, in the Iraqi Kurdistan region, and were identified by Prof. Dr. Saleem Shahbaz, of the Herbarium of the Department of Biology, Faculty of Science, University of Zakho. The plant name has been checked with <http://www.theplantlist.org> on 08.24.2019. The plant is neither endangered nor protected in Kurdistan, and no specific permission was required for the collection. A voucher has been deposited at the Herbarium with the accession number AC031. The leaves were rinsed with tap water, air-dried for about twenty days at 20--25 °C in the shade, and ground in an electrical mill (IKA-WERKE, Staufen im Breisgau, Germany) to a fine powder just prior to extraction.

3.2. Chemicals {#sec3dot2-molecules-25-00804}
--------------

Heparin and racemic ketamine were purchased from Hikma Pharmaceuticals (Amman, Jordan); xylazine, phenylephrine hydrochloride, TEA, L-NAME from Sigma-Aldrich (St. Louis, MO, USA); nifedipine from Medochemie (Limassol, Cyprus); ACh from Acros Organics--Fisher Scientific (Madison, WI, USA).

3.3. Isolation of Volatile Fractions EO {#sec3dot3-molecules-25-00804}
---------------------------------------

Five volatile fractions EO were obtained as dense oils by two different procedures: (i) Hydrodistillation provided fractions EO~S~, EO~W~, EO~A~, and EOAr (see [Section 3.3](#sec3dot3-molecules-25-00804){ref-type="sec"}); (ii) CO~2~ extraction at atmospheric pressure afforded fraction EO~D~ (see [Section 3.4](#sec3dot4-molecules-25-00804){ref-type="sec"}). All samples were dissolved in dichloromethane and analyzed by GC-FID and GC-MS.

3.4. Hydrodistillation {#sec3dot4-molecules-25-00804}
----------------------

Powdered air-dried leaves of *E. camaldulensis* were hydrodistilled in a standard Clevenger-type apparatus, by two different procedures, A and B. In procedure A, named *hydrodistillation with circulating-water*, condensed water was circulating, while water was not circulating in procedure B. In mode A, leaves (3 lots of 250 g each) were hydrodistilled and volatiles were collected in a cylindrical glass condenser, where an oily layer (labeled EO~S~) accumulated at the top of an aqueous phase. The latter could return by gravity to the distillation pot connected to the tip of the collector tube through a plastic tube. Water condensation and dipping in the pot were synchronized, so as to leave about 10 mL of an aqueous layer in the condenser. After 2.5 h of distillation no more oil apparently accumulated at the top of the aqueous phase. EO~S~ was carefully separated from the aqueous layer by a micropipette, dried over anhydrous Na~2~SO~4~, filtered using Whatman filter paper (No.1), and stored at −20 °C in a sealed vial until analysis. The average yield over 3 distillations was 0.98 ± 0.02% (*w*/*w*). This oil was considered as the reference essential oil of *E. camaldulensis* leaves. In mode B. named *hydrodistillation with non-circulating-water*, the leaves were hydrodistilled (3 repetitions from lots of 250 g each) while the total condensed aqueous phase remained in the collector tube during the entire distillation time (2.5 h). After 1 h from the end of distillation, two phases clearly separated in the condenser. The accumulated oily layer, labeled EO~W~ \[average yield 0.88 ± 0.02% (*w*/*w*)\] was carefully removed from the top of the hydrosol and treated as described for EO~S~. The condensed aromatic aqueous layer (Aq, about 750 mL) from each hydrodistillation was subjected to multiple solid phase extraction (SPE). To this purpose, a home-made cartridge was prepared by packing 10 g of Lichroprep RP-18 powder inside a glass syringe-like tube; subsequently, the reversed phase was washed with MeOH (50 mL), followed by deionized water (50 mL), and then dried under vacuum. Each fraction Aq was divided in 80 mL portions, which were individually subjected to SPE. Each portion was added to the top of the column, which was then drained out under vacuum, collecting the liquid (F). The column was then washed with MeOH (50 mL), and the eluate (E) was collected. The experiment was then repeated with a new portion of Aq, following an identical procedure. Subsequently, all F and E fractions were separately collected together and carefully evaporated under reduced pressure (200 mmHg) to give two oily residues, EO~Ar~ (average yield 0.05 ± 0.015%) and EO~A~ (average yield 0.28 ± 0.01%), respectively, which were stored under N~2~ in sealed vials at −20 °C until analysis.

3.5. CO~2~ Extraction {#sec3dot5-molecules-25-00804}
---------------------

A sample of powdered dried leaves (250 g) was submitted to CO~2~ extraction at atmospheric pressure for 2 h, in a home-made glass equipment, according to the method described by Honkanen and Karvonen \[[@B36-molecules-25-00804]\]. An oily residue (EO~D~, yield = 0.004%) was obtained which was stored under N~2~ in a sealed vial at −20 °C until analysis. Given the low yield, CO~2~ extraction was not repeated.

3.6. GC-FID Analysis {#sec3dot6-molecules-25-00804}
--------------------

GC-FID analyses of the different volatile fractions (EO) were performed on a Perkin Elmer Auto system gas chromatographer equipped with a HP5 capillary column (25 m × 0.32 mm i.d.; 0.52 µm film thickness). Nitrogen was used as the carrier gas at a flow rate of 1.5 mL/min. The injector operated in split mode (split ratio 25:1) and was heated at 220 °C. The GC oven temperature was hold at 60 °C for 1 min, then increased by a gradient of 3 °C/min until 100 °C, hold at 100 °C for 30 min, then increased to 250 °C by a gradient of 10 °C/min, finally hold at 250 °C for 5 min. Each analysis lasted 64.3 min. One microliter of each oil (5% in CH~2~Cl~2~) was injected in each analysis. Percentages (%) of compounds \> 0.01 occurring in each EO ([Table 1](#molecules-25-00804-t001){ref-type="table"}) were calculated from the corresponding GC peak areas with respect to the total peak area in the GC-FID chromatogram without applying any correction factor. Three GC-FID analyses were performed for EO~S~ and EO~W~, while EO~A~, EO~Ar~, and EO~D~ were analysed only once.

3.7. GC-MS Analysis {#sec3dot7-molecules-25-00804}
-------------------

GC-MS analyses of the different volatile fractions (EO) were performed using an Agilent Bench Top GC-MS equipment, comprising a 6890N network gas-chromatographic system combined with a 5973 Network Mass Selective Detector (Agilent Technologies, Wilmington, DE, USA), and equipped with a DB-5 glass capillary column (30 m × 0.25 mm i.d.; 0.25 µm film thickness). Helium was used as the carrier gas at a flow rate of 1 mL/min. Temperature of the injector: 220 °C; oven temperature program: isotherm at 60 °C for 1 min, then increased (3 °C/min) to 270 °C, followed by an isotherm at 270 °C for 5 min. Sample split ratio: 1:20; 1 µL of each oil (5% in CH~2~Cl~2~) was injected in each analysis. Mass spectra were acquired at 70 eV within a mass range of 41--350 Daltons (Da) with a scan time of 0.73 scans s^−1^; ion source temperature: 230 °C. Compound identification was at first based on their linear retention indices (LRIs). They were calculated according to Van Den Dool and Kratz \[[@B20-molecules-25-00804]\], with reference to a homologous series of *n*-alkanes C~6~-C~20~ (TPH-6RPM of CHEM SERVICE), which were injected immediately after each oil analysis under the same gas-chromatographic conditions. Calculated LRIs were compared with the retention indices of authentic samples or literature data \[[@B18-molecules-25-00804],[@B19-molecules-25-00804]\]. Comparison of the retention indices was considered reasonable in a range of ±20 units. The identity of each EO constituents was confirmed by comparing the mass spectral fragmentation patterns with those reported in the literature \[[@B18-molecules-25-00804],[@B19-molecules-25-00804],[@B21-molecules-25-00804]\] and, whenever possible, with the GC-MS data of pure standard compounds.

3.8. Physiological Activities of Volatile Fractions {#sec3dot8-molecules-25-00804}
---------------------------------------------------

Experiments on rats were performed according to the Iraqi and institutional rules considering animal experiments, and in accordance with the internationally accepted principles for laboratory animal use and care as found in the European Community guidelines (EEC Directive of 1986; 86/609/EEC). Stock solutions (0.05% g/L) of tested volatile fractions and 1,8-cineole were prepared by dissolving the desired amount in DMSO in which samples are completely soluble and which helped dissolution in water. They were kept refrigerated until analysis. Desired serial dilutions were then prepared by diluting stock solutions with aqueous NaCl (0.09% g/L) and warmed to 37 °C prior to use.

3.9. Measurement of Isometric Force with Isolated Thoracic Aortic Rings {#sec3dot9-molecules-25-00804}
-----------------------------------------------------------------------

Adult male albino rats, weighting 200--300 g each, were used for all experiments. They were kept in plastic cages at 24 °C and were exposed to a photoperiod cycle of 12 h light followed by 12 h darkness. Rats were fed standard diet and tap water. Access to water was free, while food was removed 24 h prior to experiments. Rats were injected intraperitoneally with heparin (1500 units/Kg body weight), then left for 30 min to avoid blood clotting and possible damage of the aorta endothelium, and finally anaesthetized with racemic ketamine (40 mg/kg) and xylazine (10 mg/kg) intraperitoneally. Chest cavity was opened, and excess tissues and fat were removed. Aorta was isolated and transferred to a beaker containing a Krebs solution aerated with 95% O~2~ and 5% CO~2~, that was placed in a water-bath at 37 °C. Subsequently, the aorta was segmented into rings 3--5 mm long. Isolated thoracic aortic rings were used in preparations with intact endothelium. Aortic rings were mounted between two stainless steel hooks, connected by a thread to a force transducer coupled to a transbridge amplifier and a Power Lab Data Acquisition system (model ML 870, Power Lab, AD Instrument, Sydney, Australia), which was connected to a computer running chart software (Version 7). The isometric force produced was monitored and recorded. Experiments were performed in 10 mL organ baths filled with a physiological Krebs solution (pH = 7.4) maintained at 37 °C by means of a thermoregulating system with water continuously circulating throughout a double-walled water-jacketed system, and continuously gassed with 95% O~2~ and 5% CO~2~. Tension was set at 2 g for 60 min, and the buffer solution was changed every 15 min until the resting tone became constant. After these numerous washings most xylazine was considered to have been removed from the organ so that its effect on the tissue was negligible. Sample concentration--response curves were then determined, with phenilephrine (1 μM) used as the aorta ring-contraction agonist.

3.10. Measurement of Isometric Force with Isolated Tracheal Rings {#sec3dot10-molecules-25-00804}
-----------------------------------------------------------------

Trachea was removed from anaesthetized rats, cleaned, and segmented into 3--5 mm long rings (each containing 3--4 cartilaginous rings). Measurements of the isometric force with isolated tracheal rings were then performed according to international standard procedures for in vitro study using organ bath. Rings were suspended in 10 mL organ baths filled with physiological Krebs solution (pH = 7.4), maintained at 37 °C by a thermoregulating system with continuous water circulating throughout a double walled water jacket system, and aerated with 95% O~2~ and 5% CO~2~. Tracheal rings were maintained under an isometric tension of 2 g and allowed to stabilize for 60 min, while changing the Krebs solution every 15 min. After these numerous washings most xylazine was considered to have been removed from trachea so that its effect on the tissue was negligible. Concentration--response curves ([Figure 3](#molecules-25-00804-f003){ref-type="fig"}, [Figure 4](#molecules-25-00804-f004){ref-type="fig"}, [Figure 5](#molecules-25-00804-f005){ref-type="fig"} and [Figure 6](#molecules-25-00804-f006){ref-type="fig"} and [Table 3](#molecules-25-00804-t003){ref-type="table"}) were then determined adding increasing amounts of EO~S~ and 1,8-cineole, in separate experiments. ACh (10 μM) was used as the tracheal ring-contraction agonist. In subsequent experiments, increasing amounts of EO~S~ were added to tracheal rings preincubated with the K^+^ channel blocker TEA (1 mM) for 20 min and then precontracted with ACh (10 μM). Analogous experiments were performed with tracheal rings preincubated with nifedipine (30 μM) for 10 min prior to precontraction with ACh (10 μM). Finally, tracheal rings were preincubated with L-NAME (0.3 mM) for 10 min. prior to precontraction with ACh (10 μM); then, increasing amounts of EO~S~ were added.

3.11. Statistical Analysis {#sec3dot11-molecules-25-00804}
--------------------------

The vasorelaxation response, calculated as a percentage of contraction produced by PE or ACh, was expressed as the mean ± standard error of the mean (SEM). The base line tension was expressed as a measure of 100% relaxation, and the tension induced by agonist was taken as a measure of 0% relaxation. All data analyses were fitted with a Hill equation, that the median effective concentration (Log of IC~50~) value was given as geometric mean with 95% confidence intervals (95% CI), using the statistics program GraphPad Prism^™^ software, version 6 (GraphPad Software, Inc., San Diego, CA, USA). Two-way analysis of variance (ANOVA) was performed, supported with Bonferroni test when carrying out pairwise comparison between the same doses of different groups using GraphPad program. *p*-Values less than 0.05 (*p* \< 0.05) were considered significant. Symbols \* mean *p* \< 0.05, \*\* *p* \< 0.01 and \*\*\* *p* \< 0.001 for all graphs.

4. Conclusions {#sec4-molecules-25-00804}
==============

In this study the chemical profiles of the volatile fractions isolated from air-dried leaves of *E. camaldulensis* Dehnh. collected in Iraqi Kurdistan, were investigated for the first time. Essential oils EO~S~ and EO~W~, respectively, were obtained by hydrodistillation with circulating water and with non-circulating-water, respectively. They were compared with an oil (EO~D~) obtained by CO~2~ extraction. The first two methods were much more efficient in terms of oil yield and number of oil components. A total of 31 and 42 components have been identified and quantified in EO~S~ and EO~W~, respectively, by GC-FID and GC-MS, and comparison with literature databases. They accounted for more than 98% of the contents of the two oils. In both EO~S~ and EO~W~, monoterpenoids prevailed over sesquiterpenoids, and oxygenated monoterpenes were more abundant than monoterpene hydrocarbons. The major components of EO~S~ and EO~W~, accounting for more than 80%, were 1,8-cineole (**1**, about 60%), followed by *p*-cymene (**2**), α-pinene (**3**), terpinen-4-ol (**4**), aromadendrene (**5**), and α-terpineol (**6**).

In conclusion, the volatile fractions isolated from *E. camaldulensis* leaves collected in Kurdistan contained important and widely used flavor and fragrance ingredients. Most constituents, mainly 1,8-cineole (**1**) and other oxygenated monoterpenoids, are biologically active, exhibiting well-known antibacterial, bronchodilatory, anti-inflammatory, and analgesic effects \[[@B2-molecules-25-00804],[@B5-molecules-25-00804],[@B26-molecules-25-00804],[@B27-molecules-25-00804],[@B28-molecules-25-00804],[@B29-molecules-25-00804],[@B30-molecules-25-00804],[@B31-molecules-25-00804],[@B32-molecules-25-00804],[@B33-molecules-25-00804],[@B37-molecules-25-00804],[@B38-molecules-25-00804]\]. In this regard, we have shown that the relaxant activity of the volatile fractions does not depend only on the most abundant constituent, 1,8-cineole (**1**), but it is likely due to the synergistic effects of different monoterpenoids. An important pathway for the relaxation effects exerted by *E. camaldulensis* volatile fractions involves the inhibition of Ca^2+^ influx through the plasma membrane in tracheal smooth muscle.

We are all well-aware that the chemical composition of vapors inhaled from a leaf hot tea can be different from that of a volatile fraction isolated by hydrodistillation, such as EO~S~, and should be analyzed by techniques such as solid phase microextraction (SPME)-GC-MS. However, it appears plausible that most of the bioactive components of the EOs also occur in the vapors, although the relative percentages can be different. Thus, based on our findings, we believe that inhalation of vapors from a hot aqueous infusion of *E. camaldulensis* leaves for treating the symptoms of respiratory tract diseases, is sustained by scientific evidence.
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![Structures of main components of leaf essential oil isolated from *E. camaldulensis* collected in the Iraqi--Kurdistan Region: 1,8-cineole (**1**), *p*-cymene (**2**), α-pinene (**3**), terpinen-4-ol (**4**), aromadendrene (**5**), and α-terpineol (**6**).](molecules-25-00804-g001){#molecules-25-00804-f001}

![Concentration--response curves for the relaxant effects of volatile fractions EO~S~, EO~W~, and EO~Ar~ on rat aortic rings precontracted with phenylephrine (1 μM). \* *p* \< 0.05, \*\* *p* \< 0.01 and \*\*\* *p* \< 0.001.](molecules-25-00804-g002){#molecules-25-00804-f002}

![Concentration--response curves for the relaxant effects of 1,8-cineole (**1**) and EO~S~ on rat tracheal rings, precontracted with ACh (10 μM).](molecules-25-00804-g003){#molecules-25-00804-f003}

![Concentration--response curves for the relaxant effects of EO~S~ on rat tracheal rings precontracted with ACh (10 μM): control and preincubated with TEA (1 mM).](molecules-25-00804-g004){#molecules-25-00804-f004}

![Concentration--response curves for the relaxant effects of EO~S~ on rat tracheal rings precontracted with ACh (10 μM): control and preincubated with nifedipine (30 μM). \*\*\* *p* \< 0.001.](molecules-25-00804-g005){#molecules-25-00804-f005}

![Concentration--response curves for the relaxant effects of EO~S~ on rat tracheal rings precontracted with ACh (10 μM): control and preincubated with L-NAME (0.3 mM).](molecules-25-00804-g006){#molecules-25-00804-f006}

molecules-25-00804-t001_Table 1

###### 

Chemical components and their percentages (%) in the different volatile fractions (EO) isolated from *E. camaldulensis* leaves ^a^.

  Component                             *RI* ^b^            *LRI* ^c^    EO~S~ ^d^    EO~W~ ^d^    EO~A~        EO~Ar~       EO~Tot~ ^e^   EO~D~
  ------------------------------------- ------------------- ------------ ------------ ------------ ------------ ------------ ------------- -------
  Isovaleric acid ^f^                   848                 842          ‒            ‒            ‒            0.23         \< 0.01       ‒
  Isopentyl acetate                     869                 870          0.07         0.07         ‒            ‒            0.05          ‒
  Undetermined                                              919          0.06         0.02         ‒            ‒            0.01          ‒
  α-Pinene ^g^ (**3**)                  932                 925          4.71         3.75         ‒            ‒            2.73          1.89
  4-Methylvaleric acid ^f^              949                 946          ‒            ‒            ‒            0.01         \<0.01        ‒
  Hexanoic acid ^f^                     990                 993          ‒            ‒            ‒            0.01         \<0.01        ‒
  *p*-Cymene (**2**)                    1020                1024         6.70         6.55         0.16         ‒            4.80          3.44
  1,8-Cineole ^g^ (**1**)               1026                1031         62.70        59.09        53.41        10.14        55.83         89.25
  Phenylacetaldehyde ^f,g^              1047                1048         ‒            ‒            0.11         0.06         0.03          ‒
  *p*-Mentha-3,8-diene                  1068                1065         2.44         2.28         ‒            ‒            1.66          1.32
  *p*-Cymenene                          1089                1090         0.15         0.17         0.13         0.13         0.16          ‒
  Isopentyl isovalerate                 1102                1107         0.28         0.38         ‒            ‒            0.28          0.15
  *endo*-Fenchol                        1114                1110         0.14         0.21         ‒            ‒            0.15          ‒
  *cis*-*p*-Menth-2-en-1-ol             1118                1120         ‒            ‒            0.16         0.22         0.05          ‒
  α-Campholenal                         1122                1122         0.05         0.18         0.36         0.6          0.24          ‒
  *trans*-Pinocarveol                   1135                1138         0.94         0.95         ‒            3.55         0.83          ‒
  *trans-p*-Menth-2-en-1-ol             1136                1140         0.13         0.03         ‒            0.16         0.03          ‒
  Sabina ketone                         1154                1151         0.05         0.04         1.93         0.03         0.48          ‒
  Pinocarvone                           1160                1162         0.62         ‒            ‒            ‒            ‒             ‒
  Umbellulone                           1167                1162         ‒            0.31         0.23         0.01         0.28          ‒
  Borneol^g^                            1165                1166         0.09         0.47         1.47                      0.68          ‒
  Terpinen-4-ol ^g^ (**4**)             1174                1177         3.86         3.90         6.96         2.70         4.56          0.39
  Cryptone                              1183                1184         1.34         1.10         6.69         13.92        2.90          ‒
  *p*-Cymen-8-ol                        1179                1187         ‒            ‒            ‒            13.48        0.53          ‒
  α-Terpineol ^g^ (**6**)               1186                1189         2.85         2.94         6.70         17.26        4.38          0.09
  Undetermined                                              1213         0.25         0.25         ‒            0.01         0.18          ‒
  *trans*-Carveol ^g^                   1215                1219         0.14         0.15         0.65         1.02         0.30          ‒
  *cis*-Carveol ^g^                     1229                1222         ‒            ‒            0.91         2.07         0.29          ‒
  *cis-p*-Mentha-1(7),8-dien-2-ol       1227                1227         ‒            0.19         1.21         2.12         0.50          ‒
  (*E*)-Ocimenone                       1235                1231         0.19                      1.73         3.81         0.55          ‒
  Cuminaldehyde                         1238                1238         0.11         0.12         0.32         0.39         0.18          ‒
  Carvone ^g^ + carvotanacetone         1239-1244           1244-1246    ‒            ‒            0.32         0.55         0.10          ‒
  Piperitone ^g^                        1249 ^a^,1254 ^d^   1254         0.11         0.11         0.47         0.92         0.23          ‒
  *p*-Menth-1-en-7-al                   1273                1274         0.73         0.68         1.67         3.41         1.02          ‒
  α-Terpinen-7-al                       1283                1283         ‒            ‒            ‒            0.01         tr            ‒
  Thymol ^g^                            1289                1289         0.49         0.58         1.78         2.52         0.93          ‒
  *p*-Cymen-7-ol                        1289                1292         ‒            ‒            0.24         0.49         0.07          ‒
  Carvacrol ^g^                         1298                1302         0.39         0.44         1.15         2.73         0.69          ‒
  3-Oxo-*p*-menth-1-en-7-al             1330                1335         ‒            ‒            0.35         0.39         0.10          ‒
  Undetermined                                              1334         0.10         0.09         0.59         0.79         0.23          ‒
  Undetermined                                              1353         ‒                         0.17         0.11         0.04          ‒
  Isoledene                             1374                1376         ‒            0.09         ‒            ‒            0.06          ‒
  α-Copaene                             1374                1378         ‒            0.08         ‒            ‒            0.07          ‒
  β-Elemene                             1389                1394         ‒            0.03         ‒            ‒            0.02          ‒
  Undetermined                                              1419         ‒            ‒            0.13         0.06         0.03          ‒
  Undetermined                                              1434         ‒            ‒            0.17         0.05         0.04          ‒
  α-Gurjunene                           1409                1412         ‒            0.03         ‒            ‒            0.02          ‒
  β-Gurjunene                           1433                1432         ‒            0.04         ‒            ‒            0.03          ‒
  Aromadendrene (**5**)                 1439                1443         3.08         3.97         0.3          0.15         2.97          0.47
  9-*epi*-(*E*)-Caryophyllene           1464                1465         1.99         2.57         0.17         0.02         1.91          ‒
  γ-Gurjunene                           1475                1476         ‒            0.06         ‒            ‒            0.04          ‒
  γ-Muurolene                           1478                1480         ‒            0.43         ‒            ‒            0.31          ‒
  2-Phenylethyl 3-methylbutanoate       1490                1493         0.16         0.72         0.29         0.27         0.60          ‒
  Viridiflorene                         1496                1499         ‒            0.28         ‒            ‒            0.20          ‒
  Undetermined                          1520                1534         ‒            ‒            0.10         0.22         0.03          ‒
  α-Muurolene                           1500                1504         ‒            0.28         ‒            ‒            0.20          0.42
  γ-Cadinene                            1513                1518         ‒            0.07         ‒            ‒            0.05          ‒
  Palustrol                             1567                1566         0.29         0.60         0.13         0.22         0.48          ‒
  Spathulenol                           1577                1584         1.65         1.72         2.57         5.74         2.08          2.58
  Globulol                              1590                1590         1.65         1.96         0.18         0.29         1.48          ‒
  Viridiflorol                          1592                1598         ‒            0.48         ‒            ‒            0.35          ‒
  Isoaromadendrene epoxide ^f^          1612                1610         0.37         ‒            0.20         0.23         0.05          ‒
  Undetermined                                              1630         0.21         0.45         0.13         0.19         0.36          ‒
  Occidenol                             1676                1670         ‒            ‒            0.32         0.57         0.10          ‒
  Undetermined                                              1680         ‒            ‒            0.11         0.18         0.03          ‒
  Nootkatol                             1714                1721         ‒            ‒            0.02         0.01         tr            ‒
  Undetermined                                              1727         ‒            ‒            0.74         1.64         0.24          ‒
  Undetermined                                              1751         ‒            ‒            0.68         1.53         0.22          ‒
  14-Oxy-α-muurolene                    1767                1766         0.10         0.10         ‒            ‒            0.07          ‒
  Undetermined                                              1774         ‒            ‒            0.37         0.63         0.11          ‒
  Undetermined                                              1855         ‒            ‒            0.05         0.12         0.02          ‒
  11,12-Dihydroxyvalencene              1914                1908         ‒            ‒            0.20         0.55         0.07          ‒
  Monoterpene hydrocarbons (4) ^h^                          14.00 (4)    12.75 (4)    0.29 (2)     0.13 (1)     9.35 (4)     6.65 (3)      
  Oxygenated monoterpenoids (28) ^h^                        74.93 (18)   71.49 (18)   88.71 (22)   82.50 (25)   75.90 (27)   89.73 (3)     
  Sesquiterpene hydrocarbons (12) ^h^                       5.07 (2)     7.93 (12)    0.47 (2)     0.17 (2)     5.88 (12)    0.89 (2)      
  Oxygenated sesquiterpenoids (9) ^h^                       4.06 (4)     4.86 (5)     3.62 (7)     7.61 (7)     4.68 (9)     2.58 (1)      
  Others (7) ^h^                                            0.51 (3)     1.17 (3)     0.40 (2)     0.58 (5)     0.96 (7)     0.15 (1)      
  Undetermined (13) ^h^                                     0.62 (4)     0.81 (4)     3.24 (11)    5.53 (12)    1.54 (13)    0.00 (0)      
  Total % ^h^                                               98.57 (31)   98.20 (42)   93.49 (35)   90.99 (40)   96.77 (59)   100 (10)      

^a^ Only peaks with a % \> 0.01 have been considered; ^b^ *R*etention *I*ndex on a DB-5 column reported in the literature \[[@B18-molecules-25-00804],[@B19-molecules-25-00804]\]; ^c^ *L*inear *R*etention *I*ndex on a DB-5 column calculated according to Van del Dool and Kratz \[[@B20-molecules-25-00804]\]; ^d^ mean percentages of three analyses; ^e^ The EO~Tot~ value of each compound corresponds to the sum of the percentages in EO~W~, EO~A~, and EO~Ar~, respectively, averaged by the weight of each fraction; ^f^ tentatively identified by comparison with the *RI* and the mass spectra reported in databases \[[@B19-molecules-25-00804],[@B21-molecules-25-00804]\]; ^g^ compound identity confirmed by coelution (GC) with an authentic sample; ^h^ Compound families and (total number) of compounds in each family over all EO's.

molecules-25-00804-t002_Table 2

###### 

Relaxant effects of EO~S~, EO~W~, and EO~Ar~ on rat aortic rings precontracted with phenylephrine (1 μM).

                          EO~S~            EO~W~            EO~Ar~
  ----------------------- ---------------- ---------------- ----------------
  Log EC~50~              0.3384           0.3689           0.4852
  95% CI for Log EC~50~   0.2974--0.3795   0.2627--0.4571   0.3621--0.6084
  Relaxation (%) ± SEM    95.66 ± 0.198    88.17 ± 11.4     72.09 ± 10.61

molecules-25-00804-t003_Table 3

###### 

Relaxant effects of volatile fractions (EO~S~) in tracheal rings preincubated with K^+^ and Ca^2+^ channel blockers, and with NG-nitro-L-arginine methyl ester (L-NAME), respectively.

  Treatment of Tracheal Rings   Control          Preincubated with TEA (1 mM)   Preincubated with Nifedizpine (30 μM)   Preincubated with L-NAME (0.3 mM)
  ----------------------------- ---------------- ------------------------------ --------------------------------------- -----------------------------------
  Log EC~50~                    0.508            0.505                          0.156                                   1.014
  95% CI for Log EC~50~         (Very wide)      (Very wide)                    --0.0466 to 0.3577                      (Very wide)
  Relaxation (%) ± SEM          79.44% ± 9.101   73.68% ± 10.39                 −26.42% ± 10.79                         45.41% ± 10.31
